Neoadjuvant sunitinib facilitates nephron-sparing surgery and ... - UroToday PDF Print
UroTodayBilateral Renal Cell Carcinoma (RCC) is an uncommon clinical entity, affecting 3%-6% of patients with localized RCC. Sunitinib has proven efficacy in the

... read more

 
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.